☰

Ryan K. Lanier, Ph.D. - Publications

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Psychoneuroimmunology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Henningfield J, Gauvin D, Bifari F, Fant R, Shram M, Buchhalter A, Ashworth J, Lanier R, Pappagallo M, Inturrisi C, Folli F, Traversa S, Manfredi PL. REL-1017 (esmethadone; D-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats. Scientific Reports. 12: 11389. PMID 35794162 DOI: 10.1038/s41598-022-15055-3  0.413
2011 Duke AN, Bigelow GE, Lanier RK, Strain EC. Discriminative stimulus effects of tramadol in humans Journal of Pharmacology and Experimental Therapeutics. 338: 255-262. PMID 21467190 DOI: 10.1124/jpet.111.181131  0.444
2010 Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC. Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology. 211: 457-66. PMID 20589494 DOI: 10.1007/S00213-010-1919-3  0.588
2010 Mintzer MZ, Lanier RK, Lofwall MR, Bigelow GE, Strain EC. Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug and Alcohol Dependence. 111: 265-8. PMID 20538418 DOI: 10.1016/J.Drugalcdep.2010.05.002  0.589
2010 Tompkins DA, Lanier RK, Harrison JA, Strain EC, Bigelow GE. Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone. Psychopharmacology. 210: 471-80. PMID 20386884 DOI: 10.1007/S00213-010-1838-3  0.44
2008 Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE. Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation. Psychopharmacology. 198: 149-58. PMID 18327673 DOI: 10.1007/S00213-008-1105-Z  0.409
2007 Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE. Evaluation of a transdermal buprenorphine formulation in opioid detoxification. Addiction (Abingdon, England). 102: 1648-56. PMID 17854341 DOI: 10.1111/J.1360-0443.2007.01944.X  0.342
2002 Lanier RK, Ijames SG, Carrigan KA, Carelli RM, Lysle DT. Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase. Drug and Alcohol Dependence. 66: 225-33. PMID 12062457 DOI: 10.1016/S0376-8716(01)00203-4  0.37
Show low-probability matches.